In a significant development for the gene and cell therapy landscape, a coalition of nonprofit organizations has announced the launch of a marketplace aimed at reviving shelved cell and gene therapy (CGT) programs. This initiative, highlighted by OTXL’s COO Beth White, is designed to breathe new life into CGT projects that have been stalled due to funding or regulatory challenges, potentially transforming the therapeutic landscape for patients with unmet medical needs.
The establishment of this marketplace comes at a time when the CGT sector faces increasing scrutiny over the viability of numerous programs that have yet to reach commercialization. By facilitating partnerships and resource sharing among stakeholders, the marketplace could streamline the path to development for promising therapies that might otherwise remain dormant. This collaborative approach not only underscores the critical role of nonprofits in advancing healthcare innovation but also signals a shift towards more integrated efforts in the biopharmaceutical industry.
Start your 7-day trial and see what the database can do →
